These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 2270028)

  • 1. [Diet therapy of hyperlipidemia].
    Yamada N
    Nihon Rinsho; 1990 Nov; 48(11):2605-12. PubMed ID: 2270028
    [No Abstract]   [Full Text] [Related]  

  • 2. A double-blind, randomized, controlled trial of the effects of two eggs per day in moderately hypercholesterolemic and combined hyperlipidemic subjects taught the NCEP step I diet.
    Knopp RH; Retzlaff BM; Walden CE; Dowdy AA; Tsunehara CH; Austin MA; Nguyen T
    J Am Coll Nutr; 1997 Dec; 16(6):551-61. PubMed ID: 9430083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diet therapy in hyperlipidemia].
    Ikeda Y; Ozaki M; Kondoh H
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():533-7. PubMed ID: 11347126
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice.
    Shi W; Wang X; Wong J; Hedrick CC; Wong H; Castellani LW; Lusis AJ
    Biochem Biophys Res Commun; 2004 Apr; 317(1):223-9. PubMed ID: 15047172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage beta3 integrin suppresses hyperlipidemia-induced inflammation by modulating TNFalpha expression.
    Schneider JG; Zhu Y; Coleman T; Semenkovich CF
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2699-706. PubMed ID: 17951320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the intake of vitamins and minerals by men and women with hyperlipidemia and overweight during dietetic treatment.
    Grzybek A; Klosiewicz-Latoszek L; Targosz U
    Eur J Clin Nutr; 2002 Dec; 56(12):1162-8. PubMed ID: 12494300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms of type III hyperlipoproteinemia: The contribution of the carboxy-terminal domain of ApoE can account for the dyslipidemia that is associated with the E2/E2 phenotype.
    Kypreos KE; Li X; van Dijk KW; Havekes LM; Zannis VI
    Biochemistry; 2003 Aug; 42(33):9841-53. PubMed ID: 12924933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risks for hyperlipidemia.
    Nestruck AC; Davignon J
    Cardiol Clin; 1986 Feb; 4(1):47-56. PubMed ID: 2871933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial hypercholesterolemia: molecular, biochemical, and clinical characterization of a French-Canadian pediatric population.
    Assouline L; Levy E; Feoli-Fonseca JC; Godbout C; Lambert M
    Pediatrics; 1995 Aug; 96(2 Pt 1):239-46. PubMed ID: 7630677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol Index of foods. Teaching tool for fat-modified diets.
    Zilversmit DB
    J Am Diet Assoc; 1979 May; 74(5):562-5. PubMed ID: 438453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of low-density lipoprotein receptor gene mutations in patients with a clinical diagnosis of familial combined hyperlipidemia in a clinical setting.
    Civeira F; Jarauta E; Cenarro A; García-Otín AL; Tejedor D; Zambón D; Mallen M; Ros E; Pocoví M
    J Am Coll Cardiol; 2008 Nov; 52(19):1546-53. PubMed ID: 19007590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary and behavioral treatment of hyperlipidemia.
    Gotto AM; Foreyt JP; Scott LW
    Compr Ther; 1978 Oct; 4(10):40-8. PubMed ID: 359230
    [No Abstract]   [Full Text] [Related]  

  • 13. Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype.
    Kesäniemi YA; Ehnholm C; Miettinen TA
    J Clin Invest; 1987 Aug; 80(2):578-81. PubMed ID: 3611358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Errors in practising a so-called "reasonable" regimen (author's transl)].
    Wobbe HD; Mertz DP; Berger A; Göhmann E
    Med Klin; 1977 Jan; 72(2):55-8. PubMed ID: 189170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The composition, structural properties and binding of very-low-density and low-density lipoproteins to the LDL receptor in normo- and hypertriglyceridemia: relation to the apolipoprotein E phenotype.
    Dergunov AD; Novoselov AV; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biol Chem; 2005 May; 386(5):441-52. PubMed ID: 15927888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of diet in hyperlipidemia in renal transplant patients.
    Zaffari D; Losekann A; Santos AF; Manfroi WC; Bittar AE; Keitel E; Souza VB; Costa M; Prates VC; Kroth L; Braun ML
    Transplant Proc; 2004 May; 36(4):889-90. PubMed ID: 15194305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of glycosphingolipid synthesis induces a profound reduction of plasma cholesterol and inhibits atherosclerosis development in APOE*3 Leiden and low-density lipoprotein receptor-/- mice.
    Bietrix F; Lombardo E; van Roomen CP; Ottenhoff R; Vos M; Rensen PC; Verhoeven AJ; Aerts JM; Groen AK
    Arterioscler Thromb Vasc Biol; 2010 May; 30(5):931-7. PubMed ID: 20167657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Description of a special form of postprandial hyperlipidemia: possible cause of premature coronary heart disease].
    Wieland E; Walli AK; Niedmann PD; Lohstöter C; Kraemer A; Seidel D
    Ther Umsch; 1990 Jun; 47(6):492-8. PubMed ID: 2375006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary treatment of hyperlipidemia in the elderly.
    Myrianthopoulos M
    Clin Geriatr Med; 1987 May; 3(2):343-59. PubMed ID: 3581018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein E and low-density lipoprotein receptor gene polymorphisms in dyslipidemias-associated essential hypertension.
    Niu W; Guo X; Su Y; Qiu C
    J Hum Hypertens; 2007 Apr; 21(4):337-9. PubMed ID: 17230232
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.